<SEC-DOCUMENT>0001157523-11-005300.txt : 20110907
<SEC-HEADER>0001157523-11-005300.hdr.sgml : 20110907
<ACCEPTANCE-DATETIME>20110907091355
ACCESSION NUMBER:		0001157523-11-005300
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20110907
FILED AS OF DATE:		20110907
DATE AS OF CHANGE:		20110907

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC  /ADR/
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		111077186

	BUSINESS ADDRESS:	
		STREET 1:		BANK OF NEW YORK
		STREET 2:		48 WALL ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10286
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6852461.htm
<DESCRIPTION>ICON PLC 6-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2011 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <br>

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 14pt"><b>FORM 6-K</b></font><br><br><br><font style="font-size: 12pt"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><br><br><font style="font-size: 12pt">Washington,
      D.C. 20549</font><br><br><br><font style="font-family: Times New Roman; font-size: 12pt"><b>Report
      of Foreign Private Issuer</b></font><br><font style="font-family: Times New Roman; font-size: 12pt"><b>Pursuant
      to Rule 13a-16 under</b></font><br>t<font style="font-family: Times New Roman; font-size: 12pt"><b>he
      Securities Exchange Act of 1934</b></font><br><br><br>For the month ended<font style="font-family: Times New Roman; font-size: 10pt">
      September, 2011</font><br><br><br><font style="font-family: Times New Roman; font-size: 18pt"><b>ICON&#160;plc</b></font><br>(R<font style="font-family: Times New Roman; font-size: 10pt">egistrant's
      name)</font><br><br><br>0-29714<br>(Commission file number)<br><br><br>South
      County Business Park, Leopardstown, Dublin 18, Ireland<br>(Address of
      principal executive offices)<br><br>Ciaran Murray, CFO<br>South County
      Business Park Leopardstown, Dublin 18, Ireland.<br>Ciaran.Murray@iconplc.com<br>0011-353-1-291-2000<br>(Name,
      telephone number, email and/or facsmile number and address of Company
      contact person)<br><br>
    </p>
    <p>
      Indicate by check mark whether the registrant files or will file annual
      reports under cover Form 20-F or Form 40-F.<br>
    </p>
    <p style="text-align: center">
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes___<u><b>X</b></u>___&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No___<b>_</b>___<br><br>
    </p>
    <p>
      Indicate by check mark whether the registrant is submitting the Form 6-K
      in paper as permitted by Regulation S-T Rule 101(b)(1):<br>
    </p>
    <p style="white-space: nowrap; text-align: center">
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No___<u><b>X</b></u>___<br><br>
    </p>
    <p>
      Indicate by check mark whether the registrant is submitting the Form 6-K
      in paper as permitted by Regulation S-T Rule 101(b)(7):<br>
    </p>
    <p style="white-space: nowrap; text-align: center">
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes______&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No___<u><b>X</b></u>___<br><br>
    </p>
    <p>
      Indicate by check mark whether the registrant by furnishing the
      information contained in this Form is also thereby furnishing the
      information to the Commission pursuant to Rule 12g3-2(b) under the
      Securities Exchange Act of 1934.<br>
    </p>
    <p style="white-space: nowrap; text-align: center">
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes___<b>_</b>___&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No___<u><b>X</b></u>___<br><br>
    </p>
    <p style="white-space: nowrap">
      If &quot;Yes&quot; is marked, indicate below the file number assigned to the
      registrant in connection with Rule 12g3-2(b):82&#160;&#160;&#160;&#160;&#160;&#160;<b>N/A</b><br><br>
    </p>
    <div style="margin-left: 0pt; margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      <u><font style="font-size: 10pt"><b>EXHIBIT&#160;LIST</b></font></u><br>
    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px" cellspacing="0">
      <tr>
        <td style="width: 6%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>Exhibit</u>
          </p>
        </td>
        <td style="width: 2%; text-align: left; padding-left: 0.0px" valign="top">
          &#160;
        </td>
        <td style="width: 20%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>Description</u>
          </p>
        </td>
        <td style="width: 72%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 20%">

        </td>
        <td style="width: 72%; text-align: left; padding-left: 0.0px" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 6%; text-align: left; padding-left: 0.0px; padding-right: 0.0px; white-space: nowrap" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            99.1
          </p>
        </td>
        <td style="width: 2%">

        </td>
        <td style="text-align: left; padding-left: 0.0px" colspan="2" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Icon plc Press Release dated September 7, 2011.
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="margin-left: 0pt; width: 100%; margin-right: 0pt; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      <br>

    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt"><b>SIGNATURES</b></font>
    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
<div style="text-align:left">
    <table style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px" cellspacing="0">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>ICON plc</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%; text-align: left; padding-left: 0.0px" valign="top">
          Date:
        </td>
        <td style="width: 55%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            September 7, 2011
          </p>
        </td>
        <td style="width: 40%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <u>/s/ Ciaran Murray</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Ciaran Murray
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Chief Financial Officer
          </p>
        </td>
      </tr>
    </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a6852461_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2011 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 12pt"><b>ICON
      Announces Peter Gray To Retire As CEO</b></font>
    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 12pt"><b>Ciaran
      Murray named as his successor and appointed to Board</b></font>
    </p>
    <p>
      DUBLIN--(BUSINESS WIRE)--September 7, 2011--<b>ICON plc</b> <b>(NASDAQ:ICLR)
      (ISIN:IE0005711209)</b>, a global provider of outsourced development
      services to the pharmaceutical, biotechnology and medical device
      industries, today announced that Mr. Peter Gray has informed the Board
      of his decision to retire as CEO, after 14 years with the Company, the
      last 9 of which were as CEO. The Board has appointed Mr. Ciaran Murray,
      who has held the position of CFO for the last 6 years, to succeed Mr.
      Gray effective October 1, 2011. Mr. Murray has also been appointed as a
      member of the Board. Mr. Gray has agreed to take on the role of Vice
      Chairman to facilitate a smooth transition and to assist the Board in
      continuing strategic development.
    </p>
    <p>
      Dr. Bruce Given, Chairman of ICON, commented &#8220;Peter&#8217;s leadership has
      been fundamental in establishing ICON as an industry leading Company and
      creating a world class management team. His contribution to ICON&#8217;s
      growth over the last number of years and to its success cannot be
      overstated. Peter has worked closely with the Board for several years in
      its development of a robust succession plan. We are therefore delighted
      that Peter will remain as Vice Chairman and that Ciaran will take on the
      role of CEO. Ciaran brings a deep knowledge of the industry together
      with extensive operational and global experience. He has a proven track
      record and has been a key member of the management team through ICON&#8217;s
      transformation to a global leader&#8221;.
    </p>
    <p>
      &#8220;It has been a great honour to lead ICON through an extremely exciting
      phase of its development&#8221; said Peter Gray. &#8220;At a time of unprecedented
      change in the industry ICON is well positioned to capitalise on the
      investments we have been making in recent years and I believe that
      Ciaran is the right person to lead the organisation and its outstanding
      people through this next phase of growth.&#8221;
    </p>
    <p>
      Ciaran Murray commented &#8220;I am delighted to be taking on the role of CEO
      for ICON at this exciting time in our development with the business
      poised for a return to growth. I look forward to continuing to build on
      the achievements of Peter and the team to ensure that ICON continues to
      grow and enhance its position as a leading global CRO&#8221;.
    </p>
    <p>
      Following Mr. Murray&#8217;s appointment Mr. Brendan Brennan, currently Senior
      Vice President of Corporate Finance will be appointed acting CFO, and
      Mr. Diarmaid Cunningham, General Counsel, will take on the additional
      role of Company Secretary.
    </p>
    <div style="margin-left: 0pt; margin-right: 0pt; width: 100%; text-indent: 0pt; margin-bottom: 10pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <b>Mr. Ciaran Murray: Biography</b>
    </p>
    <p>
      Mr Murray graduated with a Bachelor of Commerce degree from the
      University College Dublin and qualified as a Chartered Accountant with
      PwC in 1988. Subsequently he held a number of senior financial positions
      in global organisations including Kraft Foods, Novell Inc., Northern
      Foods and Codec Systems.
    </p>
    <p>
      Mr. Murray joined ICON in 2005 as Chief Financial Officer and has been a
      key member of the Executive Management team during a period of
      exceptional growth when the company grew from $326m in revenue and 2,700
      employees to its 2010 revenues of $900m and over 8,000 employees.
    </p>
    <p>
      In addition to his financial role, Mr Murray has been responsible for
      ICON&#8217;s Medical Imaging division and has played a central role in the
      development of the ICON strategic plan.
    </p>
    <p>
      The statements made in this Press Release may contain forward-looking
      statements that involve a number of risks and uncertainties. In addition
      to the matters described in this Press Release, the ability to maintain
      large client contracts or enter into new contracts, maintain client
      relationships and the ability to manage the opening of new offices, the
      integration of new business mergers and acquisitions, as well as other
      risks and uncertainties detailed from time to time in SEC reports filed
      by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the
      actual results achieved by ICON. ICON disclaims any intent or obligation
      to update these forward-looking statements.
    </p>
    <p>
      <b>About ICON plc</b><br>ICON plc is a global provider of outsourced
      development services to the pharmaceutical, biotechnology and medical
      device industries. The Company specialises in the strategic development,
      management and analysis of programs that support clinical development -
      from compound selection to Phase I-IV clinical studies. ICON currently
      has approximately 8100 employees, operating from 78 locations in 39
      countries
    </p>
    <p>
      The Company will hold a conference call today, September 7<sup>th</sup>,
      2011 at 8:00 EST (13:00 Ireland &amp; UK). This call can be accessed via
      webcast live from our website at <u>http://www.iconplc.com</u>. A
      recording will also be available on the website for 90 days following
      the call.
    </p>
    <p>
      <b>ICON/ICLR-F</b>
    </p>
    <p>

    </p>
    <p>
      CONTACT:<br>ICON<br>Investor Relations: 1-888-381-7923<br>or<br>Ciaran
      Murray, Chief Financial Officer<br>+ 353 &#8211;1-291-2000<br>or<br>Brendan
      Brennan, Snr VP Corp Fin<br>+ 353 &#8211;1-291-2000<br>or<br>Sam
      Farthing, VP Investor Relations<br>+ 353 &#8211;1-291-2251<br>or<br>Simon
      Holmes, VP Corporate Development<br>+ 353 &#8211;1-291-2016
    </p>
    <p>

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
